Antibiotics Disrupt Balance of Gut Bacteria in Human Body

Antibiotic use is widespread globally, but these medications often disrupt the delicate balance of beneficial gut bacteria alongside eliminating harmful ones.

The intestinal microbiome, a complex community of bacteria that has co-evolved with humans, plays a vital role in digestion, immune function, and other essential processes. However, when antibiotics are taken, they can kill both good and bad bacteria, potentially creating an environment where pathogenic species thrive.

A diverse gut microbiome is generally better equipped to resist the invasion of harmful pathogens. Unfortunately, antibiotic treatment often reduces this diversity, leaving the gut ecosystem more susceptible to disease, according to researchers who have been studying the effects of these medications on the human body.

A recent study has shed new light on how sugar consumption can exacerbate the negative impact of antibiotics on the gut microbiome. The research team closely monitored meals consumed by hospitalised cancer patients and tracked changes in their gut bacteria over a 48-hour period prior to treatment.

The findings suggest that for every additional 100 grams of sugar eaten during this time, there was an observed decline of 21% in alpha diversity - a measure of the variety of beneficial bacterial species present in the gut.

The study's findings suggest that sugar consumption can exacerbate the negative impact of antibiotics on the gut microbiome.

Mouse experiments demonstrated similar results to those observed in humans, where animals exposed to biapenem while consuming dietary sucrose experienced a significant increase in Enterococcus population within just three days. By day six, the bacterial burden had increased by an astonishing 33.4 times.

Co-senior author Jonas Schluter emphasized the importance of identifying factors that can minimize the unintended health risks associated with antibiotic use on the microbiome. The study's findings suggest that modifying diet during and after antibiotics could help mitigate these effects.

A key aspect of this research was its focus on patients with blood cancers, who frequently receive antibiotics and have their food intake closely monitored during hospitalization. By recording every meal and collecting daily microbiome samples, researchers were able to conduct one of the largest and most detailed studies of its kind.

The study's co-senior author Marcel van den Brink highlighted the significance of the microbiome in cancer care, particularly for patients undergoing intensive treatments such as bone marrow transplantation. The balance of beneficial bacteria in the gut can have a profound impact on treatment outcomes, recovery, and side effects.

Researchers used over 9,000 recorded meals to analyze the relationship between diet and antibiotic use on the gut microbiome. This comprehensive approach provided valuable insights into how everyday factors like sugar intake may influence a patient's response to treatment.

Patients undergoing chemotherapy and antibiotic treatment for blood cancers often spend several weeks hospitalized during this period.

Their diets and gut microbiomes can undergo significant changes as a result of the intensive medical treatment.

The loss of beneficial microorganisms in these patients allows potentially harmful species to thrive, such as Enterococcus faecium.

The research suggests that patients undergoing antibiotic treatment may want to consider reducing their sugar intake to minimize damage to their microbiome.

Cutting back on simple sugars during and after antibiotic treatment could potentially mitigate microbiome damage, according to the study's findings.

However, further investigation is needed to fully understand the mechanisms by which sugar exacerbates microbiome disruption caused by antibiotics.

The research team has emphasized that this is an area where more work is required to determine exactly how sugar contributes to the problem and whether dietary changes can improve patient outcomes.

A large group of researchers contributed to the study from various institutions, including NYU Langone Health and Memorial Sloan Kettering Cancer Center.

These authors included several co-senior authors and first authors, highlighting the collaborative nature of the research project.

The extensive list of contributors underscores the complexity of the issue being studied and the need for a multidisciplinary approach to understanding its causes and consequences.

The research team behind this study has received funding from a range of prestigious organizations, including the National Institutes of Health and several private foundations.

These grants have enabled the researchers to explore the complex interactions between sugar consumption and antibiotic use, which may lead to unintended consequences for human health.

In addition to these financial contributions, some team members have also received personal support in the form of fellowships or awards from organizations such as the Gabrielle's Angel Foundation and the American Society of Clinical Oncology Young Investigator Award.

This diverse range of funding sources underscores the interdisciplinary nature of the research being conducted, which involves collaboration between experts in fields such as microbiology, medicine, and nutrition.

The findings of this study are likely to have significant implications for public health policy and individual behavior, particularly with regard to sugar consumption and antibiotic use.